Companies/AtriCure, Inc.

Company profile

AtriCure, Inc.

NASDAQ: ATRC · Healthcare · Medical - Instruments & Supplies

PublicHQ Mason, OH · WarrenCIK 0001323885Reports USD

#204 of 1,394 Healthcare companies by revenue61st-percentile growth

EA Score

84B+

FH 80DQ 96GM 72SS 83

v0.1 · 65/100 weight · provisional

↑ filing timeliness, disclosure history · ↓ revenue growth (YoY), 3-yr revenue growth

Methodology →

Revenue TTM

$552.2M

Rev growth YoY (TTM)

+15.0%

Net income (FY)

-$11.4M

Employees

1,300

Market cap

$1.6B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$534.5M$534.5M2025

Net income-$11.4M-$11.4M2025

Operating income-$9.4M-$9.4M2025

Total assets$654.2M$654.2M2025

Liabilities$162.2M$162.2M2025

Equity$491.9M$491.9M2025

Revenue trend

FY2020 – FY2025 · USD

$40.8M

FY20

$54.8M

FY20

$206.5M

FY20

$274.3M

FY21

$330.4M

FY22

$399.2M

FY23

$465.3M

FY24

$534.5M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Shipping and Handling100%

By geography

U [S]81%

Non Us19%

The read

AtriCure, Inc. booked $534.5M in FY2025 revenue, growing 15% year over year — faster than most Healthcare companies we track, at a -2.1% net margin.

Peers · Healthcare

ArriVent BioPharma, Inc.——Novavax, Inc.69B Harrow Health, Inc.73B Innovage Holding Corp.68B

Neighbors

Warren →

LCNB Corp.$6.4M54D Pick-Ups Plus, Inc.$2.0M——

Key facts

CEOMichael H. Carrel

SectorHealthcare

IndustryMedical - Instruments & Supplies

HeadquartersMason, OH

ExchangeNASDAQ: ATRC

Employees1,300

IPO date2005-08-05

Latest filings

8-K2026-05-19 10-Q2026-05-06 8-K2026-05-05 DEF 14A2026-04-06 10-K2026-02-19 8-K2026-02-17 8-K2026-01-12 10-Q2025-10-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.